← Back to Search

Behavioural Intervention

Self-hypnosis for Hypnotherapy

N/A

Recruiting

Research Sponsored by Ciusss de L'Est de l'Île de Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be 18 years of age or older

Report pain that has been present for at least 3 months

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

"This trial is testing if self-hypnosis can help manage chronic pain. They will measure the change in pain levels over 3 and 6 months, as well as the impact on daily life,

Who is the study for?

This trial is for pain clinic patients dealing with chronic pain. It's designed to see if self-hypnosis can help manage their pain over time, looking at immediate effects and up to 6 months later. Participants should be interested in learning self-hypnosis and CBT techniques.Check my eligibility

What is being tested?

The study tests whether self-hypnosis training can reduce daily pain levels immediately and after 3-6 months. It also examines the impact on how pain affects daily life, mood (anxiety-depression), and overall quality of life.See study design

What are the potential side effects?

No side effects are expected from participating in this clinical trial as it involves non-invasive methods like self-hypnosis and psycho-education.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been experiencing pain for at least 3 months.

Select...

My pain level has been at least 4 out of 10 in the last day.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Time 1 : Hospital anxiety and depression scale (HADS)

Time 1 : Numerical Rating Scale (NRS) from 0 to 10

Time 1 : Questionnaire Brief Pain Inventory (BPI)

+2 more

Secondary outcome measures

Time 2 : Hospital anxiety and depression scale (HADS)

Time 2 : Numerical Rating Scale (NRS) from 0 to 10

Time 2 : Questionnaire Brief Pain Inventory (BPI)

+1 more

Other outcome measures

Time 3 : Hospital anxiety and depression scale (HADS)

Time 3 : Numerical Rating Scale (NRS) from 0 to 10

Time 3 : Questionnaire Brief Pain Inventory (BPI)

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Self-hypnosisExperimental Treatment1 Intervention

Group II: Psyco-education and cognitive behavioral therapyActive Control1 Intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ciusss de L'Est de l'Île de MontréalLead Sponsor

70 Previous Clinical Trials

5,500 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for participants currently open in this medical study?

"According to the details available on clinicaltrials.gov, this particular medical research trial is actively pursuing potential participants. The trial was initially disclosed on February 1st, 2024 and underwent its latest revision on February 19th, 2024."

Answered by AI

What is the current number of individuals who are being enrolled in this medical study?

"Affirmative. Per information found on clinicaltrials.gov, this research endeavor is presently seeking participants for enrollment. The trial was initially listed on 2/1/2024 and underwent the latest revision on 2/19/2024. A total of 60 individuals are sought across a solitary site for inclusion in the study."

Answered by AI

What is the main objective of this clinical trial?

"The primary endpoint of this investigation, to be evaluated within the initial 24-hour period, is represented by Time Point 1: Numerical Rating Scale (NRS) ranging from 0 to 10. Secondary endpoints consist of Time Point 2: Brief Pain Inventory (BPI), focusing on the functional impact of pain through a nine-item scale assessment; Time Point 2: SF-36 (36-Item Short Form Survey) evaluating quality of life via a survey encompassing eight health domains; and Time Point 2: Hospital Anxiety and Depression Scale (HADS) gauging anxiety-depression levels utilizing a standardized questionnaire."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Self-hypnosis Training for Chronic Pain Management

David Ogez 2024. "Self-hypnosis Training for Chronic Pain Management". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06279650.